Article Type
Case Report
Published
This report describes the case of a 72-year-old man where anticoagulation therapy was postponed due to a haemorrhagic lesion, leading to new ischaemic stroke.
Case Report
This report describes the case of a 72-year-old man where anticoagulation therapy was postponed due to a haemorrhagic lesion, leading to new ischaemic stroke.
Review
This article discusses an update to the ANIBAL protocol in light of the COVID-19 pandemic.
Original Research
In this review, the available information on the antithrombotic management of atrial fibrillation patients at discharge after COVID-19 infection is updated. In addition, a practical algorithm, considering renal and liver function, which facilitates the anticoagulation choice at discharge is presented.
Original Research
This work analyzed the clinical profile and management of patients with nonvalvular atrial fibrillation taking rivaroxaban in routine practice in Spain.
Original Research
The aim of this study was to assess whether the recommendations and guidelines for thromboprophylaxis in patients with atrial fibrillation (AF) have been adopted in general practice (GP) in the UK. The authors concluded that one in four patients with non-valvular AF, at risk of a stroke, is not being adequately treated with an oral anticoagulant in primary care and suggest that a review of GP practice databases should be considered to identify patients with non-valvular AF, at risk of a disabling or fatal event, and measures taken to initiate anticoagulant therapy.